22 results on '"Berg, M"'
Search Results
2. Risk stratification and subclinical phenotyping of dilated and/or arrhythmogenic cardiomyopathy mutation-positive relatives: CVON eDETECT consortium
3. The effect of losartan therapy on ventricular function in Marfan patients with haploinsufficient or dominant negative FBN1 mutations
4. Peripartum cardiomyopathy: Euro Observational Research Program
5. Predictors of outcome after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy. Special interest for the septal coronary anatomy
6. Recurrent and founder mutations in the Netherlands—Phospholamban p.Arg14del mutation causes arrhythmogenic cardiomyopathy
7. Rate control in atrial fibrillation, insight into the RACE II study
8. Recurrent and founder mutations in the Netherlands: the cardiac phenotype of DES founder mutations p.S13F and p.N342D
9. Recurrent and founder mutations in the Netherlands: cardiac Troponin I (TNNI3) gene mutations as a cause of severe forms of hypertrophic and restrictive cardiomyopathy
10. Recurrent and founder mutations in the Netherlands: mutation p.K217del in troponin T2, causing dilated cardiomyopathy
11. Recurrent and founder mutations in the Netherlands: Extensive clinical variability in Marfan syndrome patients with a single novel recurrent fibrillin-1 missense mutation
12. Rationale and design of the PHOspholamban RElated CArdiomyopathy intervention STudy (i-PHORECAST)
13. The Netherlands Arrhythmogenic Cardiomyopathy Registry: design and status update.
14. Founder mutations in the Netherlands
15. In-hospital mortality and three-year survival after repaired acute type A aortic dissection
16. Cardiac assessment of patients with late stage Duchenne muscular dystrophy
17. The many faces of aggressive aortic pathology: Loeys-Dietz syndrome
18. N-terminal pro B-type natriuretic peptide levels predict newly detected atrial fibrillation in a population-based cohort
19. Recurrent and founder mutations in the Netherlands-Phospholamban p.Arg14del mutation causes arrhythmogenic cardiomyopathy.
20. Recurrent and founder mutations in the Netherlands: the cardiac phenotype of DES founder mutations p.S13F and p.N342D.
21. Recurrent and founder mutations in the Netherlands: cardiac Troponin I ( TNNI3) gene mutations as a cause of severe forms of hypertrophic and restrictive cardiomyopathy.
22. Cardiac assessment of patients with late stage Duchenne muscular dystrophy.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.